HEATHER JONES: Open Payments
NPI 1205699857 · BRUNSWICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 31 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $293 · 2025 $935
Food & beverage: $890Education: $45
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 11 | $250 |
| AstraZeneca Pharmaceuticals LP | 5 | $169 |
| PFIZER INC. | 5 | $100 |
| Sumitomo Pharma America, Inc. | 1 | $83 |
| Sage Therapeutics, LLC | 1 | $80 |
| COLOPLAST CORP | 1 | $77 |
| Lilly USA, LLC | 1 | $45 |
| Exact Sciences Corporation | 2 | $36 |
| Astellas Pharma US Inc | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
Products named: VOQUEZNA, BREZTRI, MYFEMBREE, Titan, PREVNAR 20, Veozah, FARXIGA, CAPLYTA.
Industry payments across MD — which companies pay providers there.
